Literature DB >> 19359057

Effect of cardiac resynchronization therapy on the incidence of electrical storm.

Peter Nordbeck1, Bernhard Seidl, Beatrix Fey, Wolfgang R Bauer, Oliver Ritter.   

Abstract

BACKGROUND: Hemodynamic improvement from biventricular pacing is well documented; however, its electrophysiologic effects have not been systematically studied. In this study, incidence and risk factors for electrical storm (ES) were investigated in 729 ICD and biventricular defibrillator (CRT-D) heart failure patients.
METHODS: 168 consecutive CRT-D and 561 ICD patients were retrospectively analyzed for the occurrence of VT/VF and predisposing factors. Electrical storm was defined as ventricular tachycardia or fibrillation ≥3 times during 24 h. Mean follow-up was 41 months.
RESULTS: In 168 CRT-D patients only one patient experienced electrical storm compared to 39 patients out of 561 ICD patients (0.6% vs. 7%, p<0.01). 33% of the patients with electrical storm died within one year. In the CRT-D group 81 patients (48%) developed VT or VF and received at least one appropriate therapy, compared to 281 patients (50%) in the ICD group. Mean ejection fraction was 21.7% in the CRT-D group and 34.7% (p<0.01) in the ICD group. Stratifying the patients according to primary or secondary prevention and ejection fraction demonstrated that VT/VF clusters were significantly associated with ICD indication for secondary prevention, previous myocardial infarction and LVEF<30%.
CONCLUSION: The development of electrical storm is accompanied with a highly increased mortality risk even if an ICD/CRT-D is implanted. In CRT-D patients electrical storm is much less common than in ICD patients. Secondary prevention and ejection fraction<30% are predictors of electrical storm. Beside hemodynamic improvements cardiac resynchronization therapy may reduce the arrhythmia burden in heart failure patients.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19359057     DOI: 10.1016/j.ijcard.2009.03.055

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

Review 1.  The evaluation and management of electrical storm.

Authors:  Michael Eifling; Mehdi Razavi; Ali Massumi
Journal:  Tex Heart Inst J       Date:  2011

Review 2.  Electrical storm: A clinical and electrophysiological overview.

Authors:  Sergio Conti; Salvatore Pala; Viviana Biagioli; Giuseppe Del Giorno; Martina Zucchetti; Eleonora Russo; Vittoria Marino; Antonio Dello Russo; Michela Casella; Francesca Pizzamiglio; Valentina Catto; Claudio Tondo; Corrado Carbucicchio
Journal:  World J Cardiol       Date:  2015-09-26

3.  Epicardial ablation as a bailout in electrical storm?

Authors:  Ghaliah Al Mohani; Carsten Israel; Michela Casella; Corrado Carbucicchio
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-06-19

4.  Electrical storm: Incidence, Prognosis and Therapy.

Authors:  Riccardo Proietti; Antonio Sagone
Journal:  Indian Pacing Electrophysiol J       Date:  2011-03-25

5.  Upgrade from ICD to CRT-D: clinical and haemodynamic impact of biventricular pacing in a patient with acquired long QT syndrome.

Authors:  Damian Kawecki; Janusz Dola; Wojciech Jacheć; Celina Wojciechowska; Stanisław Morawski; Andrzej Tomasik; Ewa Nowalany-Kozielska
Journal:  Open Med (Wars)       Date:  2015-01-15

6.  Long-term outcome of catheter ablation and other form of therapy for electrical storm in patients with implantable cardioverter-defibrillators.

Authors:  Stanislaw Morawski; Patrycja Pruszkowska; Beata Sredniawa; Radoslaw Lenarczyk; Zbigniew Kalarus
Journal:  J Interv Card Electrophysiol       Date:  2017-10-24       Impact factor: 1.900

7.  IntErnationaL eLeCTRicAl storm registry (ELECTRA): Background, rationale, study design, and expected results.

Authors:  Federico Guerra; Michele Accogli; Paolo Bonelli; Corrado Carbucicchio; Valentina Catto; Laura Cipolletta; Gaetano Maria De Ferrari; Gabriele Dell'Era; Veronica Dusi; Oscar Fabregat-Andrés; Marco Flori; Eraldo Occhetta; Pietro Palmisano; Francesca Patani; Alessandro Proclemer; Alessandro Capucci
Journal:  Contemp Clin Trials Commun       Date:  2017-06-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.